FDA Brief

Warning letters Drugs

FDA warning letter to

LXR Biotech, LLC

Issued Jul 17, 2023Posted Aug 1, 2023Division of Pharmaceutical Quality Operations III

CGMP/Finished Pharmaceuticals/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

LXR Biotech, LLC's FDA history

  1. LXR Biotech, LLC

    FDA warns LXR Biotech over CGMP (manufacturing quality rules) failures for Eternal Energy supplements, making them adulterated (legally unfit as made).

    Medium

Full company page